Disease
|
Drug/Important Bio-Agent (IBA)
4 | 5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
01/2020
-
01/2018 |
3 | LipidsIBA
01/2019
-
01/2018 |
2 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2019
-
01/2018 |
2 | Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2019
-
01/2018 |
1 | Proteoglycans (Proteoglycan)IBA
11/2020 |
1 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2020 |
1 | Phosphates (Orthophosphate)IBA
01/2019 |
1 | Messenger RNA (mRNA)IBA
01/2019 |
1 | VitaminsIBA
01/2019 |
1 | oxidized low density lipoproteinIBA
10/2018 |
1 | Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
10/2018 |
1 | IronIBA
12/2016 |
1 | LDL Lipoproteins (beta Lipoproteins)IBA
05/2015 |
1 | Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
05/2015 |
1 | Apolipoproteins E (ApoE)IBA
05/2015 |
1 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
05/2015 |
1 | 3-Hydroxyanthranilic AcidIBA
05/2015 |
|
Therapy/Procedure
|